期刊文献+

^(18)F-PET-CT显像在肺癌纵隔淋巴结转移中临床应用价值 被引量:5

^(18)F-FDG PET-CT in detecting lymph nodes metastasis of lung cancer
暂未订购
导出
摘要 目的:探讨PET-CT显像在判断肺癌纵隔淋巴结转移中的临床应用价值。方法:回顾性分析67例肺癌患者在手术前CT、PET、PET-CT显像结果。67例肺癌患者均经手术治疗,手术共取出不同大小淋巴结319枚,其中转移淋巴结68枚,且所有取出淋巴结均经病理证实。以病理结果作为标准,分析CT、PET、PET-CT检查结果的准确性,分别计算CT、PET、PET-CT诊断的准确率、灵敏度、特异性、阳性预测值和阴性预测值等指标,并对CT、PET、PET-CT的诊断准确率进行比较。结果:CT、PET、PET-CT判断肺癌纵隔淋巴结转移的分别为74.6%、80.9%、88.7%;61.8%、80.9%、86.8%;78.1%、79.4%、89.2%;43.3%、53.4%、68.6%;88.3%、93.4%、96.1%。CT诊断纵隔淋巴结的准确率低于PET,差异无统计学意义,PET-CT诊断的准确率高于PET,P<0.05。结论:PET-CT显像对判断肺癌淋巴结转移的准确率高。 Objective: To evaluate the clinical value of PET-CT in judging mediastinal lymph nodes metastasis of lung cancer. Methods: A retrospective review of the CT, PET and PET-CT findings of 67 patients was performed. In operations, 319 mediastinal lymph nodes samples were acquired by resection, and 68 metastasis lymph nodes were proved by pathology. The accuracy, sensitivity, specificity, positive predictive value (PPV) and negative predictive val- ue (NPV) of CT, PET and PET-CT were determined. Results: In detecting mediastinal lymph node metastasis, the accuracy of CT, PET and PET-CT scans was 74.6%, 80.9% and 88.7% ; the sensitivity of them was 61.8%, 80.9% and 86.8% ;the specificity was 78.1%, 79.4% and 89.2% ; the PPV was 43.3%, 53.4% and 68.6% ; the NPV was 88.3%, 93.4% and 96.1%. The accuracy of PET-CT scans was significantly better than that of PET or CT scans in determining mediastinal lymph node metastasis( P 〈 0.01 ). Conclusion: PET-CT is more accurate than PET or CT.
出处 《山东大学学报(医学版)》 CAS 北大核心 2007年第8期846-848,857,共4页 Journal of Shandong University:Health Sciences
关键词 正电子发射断层 X线计算机 肺肿瘤 淋巴 转移 Positron emission tomography X ray computed Lung neoplasms Lymph nodes, metastasis
  • 相关文献

参考文献7

  • 1Haag DW,Follectte DW,Roberts PF,et al.Advantages of Positron emission tomography over computed tomography staging of non-small cell lung cancer[J].J Surg Res,2002,103(2):160-164.
  • 2Eschmann SM,Friedel G,Paulsen F,et al.FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy[J].Eur J Nucl Med Mol Imaging,2002,29(6):804-808.
  • 3Silvestri GA,Tanoue LT,Margolis ML,et al.The noninvasive staging of non-small cell lung cancer:the guidelines[J].Chest,2003,123(1):147-156.
  • 4Lardinois D,Weder W,Hany TF,et al.Staging of non-small cell lung cancer with integrated Positron emission tomography and computed tomography[J].New Engl J Med,2003,348(25):2500-2507.
  • 5Antoch G,Stattaus J,Nemat AT,et al.Non-small cell lung cancer:dual-modality PET/CT in preoperative staging[J].Radiology,2003,229(2):526-533.
  • 6Takamochi K,Yoshida J,Murakami K,et al.Pitfalls in lymph node staging with positron emission tomography in Non-small cell lung cancer patients[J].Lung Cancer,2005,47(2):235-242.
  • 7Chung JH,Cho KJ,Lee SS,et al.Overexpression of Glut1 in lymphoid follicles correlates with false-positive (18)F-FDG PET results in lung cancer staging[J].J Nucl Med,2004,45(6):999-1003.

同被引文献73

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部